JK Tyre Expands Banmore Plant With Phase III PCR Capacity
Company News

JK Tyre Expands Banmore Plant With Phase III PCR Capacity

JK Tyre has inaugurated Phase III of capacity expansion and modernisation at its Passenger Car Radial (PCR) manufacturing facility in Banmore, Madhya Pradesh, strengthening its position in India’s radial tyre segment. The expansion is part of a multi-phase investment of over Rs 10 billion, aimed at building a state-of-the-art hub for high-performance PCR tyre manufacturing.
The new facility was inaugurated by Hisashi Takeuchi, Managing Director and CEO, Maruti Suzuki India, in the presence of Raghupati Singhania, Chairman and Managing Director, and Anshuman Singhania, Managing Director, JK Tyre, along with the leadership team from Maruti Suzuki India.
With Phase III commissioned, the Banmore plant’s production capacity has increased to 30,000 passenger car radial tyres per day, translating to around 10.5 million tyres annually. This expansion contributes to boosting JK Tyre’s total passenger car radial tyre capacity in India to 16 million tyres per year, supporting demand from the aftermarket, OEMs and global markets.
Commenting on the development, Raghupati Singhania said, “The inauguration of Phase III expansion by Mr Hisashi Takeuchi San at our Banmore plant reflects JK Tyre’s unwavering commitment to strengthening India’s manufacturing ecosystem and supporting the country’s mobility growth story. As passenger vehicle demand continues to rise, our focus remains on incessant capacity enhancement, modernisation, and technology-led innovation. Banmore has been a cornerstone of our passenger car radial journey, and this expansion further reinforces our ability to serve OEMs and consumers with high-quality, sustainable, and future-ready products, while contributing to industrial growth and employment generation in Madhya Pradesh.”
The Banmore facility continues to play a key role in regional industrial development, supporting employment and local economic growth. It operates with a strong focus on sustainability, adopting energy-efficient processes and responsible manufacturing practices, alongside community initiatives in healthcare, education, livelihood enhancement and rural development.

JK Tyre has inaugurated Phase III of capacity expansion and modernisation at its Passenger Car Radial (PCR) manufacturing facility in Banmore, Madhya Pradesh, strengthening its position in India’s radial tyre segment. The expansion is part of a multi-phase investment of over Rs 10 billion, aimed at building a state-of-the-art hub for high-performance PCR tyre manufacturing.The new facility was inaugurated by Hisashi Takeuchi, Managing Director and CEO, Maruti Suzuki India, in the presence of Raghupati Singhania, Chairman and Managing Director, and Anshuman Singhania, Managing Director, JK Tyre, along with the leadership team from Maruti Suzuki India.With Phase III commissioned, the Banmore plant’s production capacity has increased to 30,000 passenger car radial tyres per day, translating to around 10.5 million tyres annually. This expansion contributes to boosting JK Tyre’s total passenger car radial tyre capacity in India to 16 million tyres per year, supporting demand from the aftermarket, OEMs and global markets.Commenting on the development, Raghupati Singhania said, “The inauguration of Phase III expansion by Mr Hisashi Takeuchi San at our Banmore plant reflects JK Tyre’s unwavering commitment to strengthening India’s manufacturing ecosystem and supporting the country’s mobility growth story. As passenger vehicle demand continues to rise, our focus remains on incessant capacity enhancement, modernisation, and technology-led innovation. Banmore has been a cornerstone of our passenger car radial journey, and this expansion further reinforces our ability to serve OEMs and consumers with high-quality, sustainable, and future-ready products, while contributing to industrial growth and employment generation in Madhya Pradesh.”The Banmore facility continues to play a key role in regional industrial development, supporting employment and local economic growth. It operates with a strong focus on sustainability, adopting energy-efficient processes and responsible manufacturing practices, alongside community initiatives in healthcare, education, livelihood enhancement and rural development.

Next Story
Real Estate

Puravankara Expands Portfolio With Rs 139 Billion GDV in 9MFY26

Puravankara Limited reported a strong performance in the third quarter of FY26, underpinned by higher pre-sales, improved collections and a series of strategic acquisitions that lifted its growth outlook. During 9MFY26, the Bengaluru-based developer added projects with an estimated gross development value of around Rs 139 billion, strengthening its presence across key residential micro-markets in southern and western India. Pre-sales for Q3FY26 rose 17 per cent year-on-year to Rs 14.14 billion, while customer collections increased 22 per cent to Rs 11.40 billion. The average price realisation..

Next Story
Infrastructure Energy

Oil Discoveries Boost Onshore Block 1 Prospects in Abu Dhabi

Indian Oil Corporation Limited (IOCL), together with Bharat PetroResources Limited, is jointly advancing oil exploration in Abu Dhabi’s Onshore Block 1 following encouraging discoveries in both unconventional and conventional reservoirs. The block is operated through Urja Bharat Pte Limited, a 50:50 special purpose vehicle established by the two Indian companies. UPBL was awarded the Onshore Block 1 concession in early 2019 under Abu Dhabi’s 2019 bid round. In early 2024, the company achieved its first oil discovery in the unconventional Shilaif play at the XN-76 exploratory well. After s..

Next Story
Infrastructure Urban

Firstsource Acquires TeleMedik to Expand US Healthcare Capabilities

Firstsource Solutions Limited has acquired TeleMedik to strengthen its digital healthcare offerings and expand its presence across US payer and provider markets. The acquisition enhances Firstsource’s end-to-end clinical and utilisation management capabilities and deepens its footprint across payer-provider networks. TeleMedik brings advanced clinical platforms and complementary technologies that support health plans seeking more personalised and outcome-focused care. The acquisition also strengthens Firstsource’s integrated and differentiated business process as a service offering for he..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Open In App